Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition

Meilin Hu, Haojie Peng, Guochang Qiu, Sen Liu, Qianying Li, Taizhen Liang, Jintao Lai, Fenmei Liang, Yiqiang Zhu, Xiaoqing Liu, Lixiang Xie, Yaoming Liu, Tao Chen, Bin Zhang, Haiyue Rao, Shiqi Xiao, Peiwen Li, Xiancai Ma, Xinxin Chen · 2026

Read Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition by Meilin Hu, Haojie Peng, Guochang Qiu, Sen Liu, Qianying Li, Taizhen Liang, Jintao Lai, Fenmei Liang, Yiqiang Zhu, Xiaoqing Liu, Lixiang Xie, Yaoming Liu, Tao Chen, Bin Zhang, Haiyue Rao, Shiqi Xiao, Peiwen Li, Xiancai Ma, Xinxin Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13645674.txt.

Description

Meilin Hu and colleagues attacked triple-negative breast cancer in two thousand twenty-six. This cancer subtype lacks well-defined drug targets. A DNA-tagging enzyme drives its growth and spread here. The enzyme clumps into liquid droplets inside cells. Removing it pushed cancer cells toward death. Fat-driven cell damage also increased after removal.

An existing drug dissolved those droplets directly. It bound the enzyme's disordered region physically. Silencing of protective genes then failed inside cells. Pairing that drug with a second blocker worked even better. Lung spread shrank in mouse models under the pair. Combination epigenetic therapy gains strong support here.

Catalog record

CREATORMeilin Hu, Haojie Peng, Guochang Qiu, Sen Liu, Qianying Li, Taizhen Liang, Jintao Lai, Fenmei Liang, Yiqiang Zhu, Xiaoqing Liu, Lixiang Xie, Yaoming Liu, Tao Chen, Bin Zhang, Haiyue Rao, Shiqi Xiao, Peiwen Li, Xiancai Ma, Xinxin Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13645674

Browse the full library · About the Tower of Babel